- Corporate Officers - E
- Ecor1 Capital, Llc
Insider Trading History of Ecor1 Capital, Llc
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ecor1 Capital, Llc since 2020.
This trader's CIK number is 1587114.
At the time of last reporting, Ecor1 Capital, Llc was the Officer of Adaptimmune Therapeutics Plc. (stock ticker symbol ADAP).
Also see all insider trading activities at Adaptimmune Therapeutics Plc.
Note that in the past
EcoR1 Capital, LLC also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Akouos, Inc. (AKUS) by Ecor1 Capital, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | AKUS | 1,176,000 | $19,992,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Tango Therapeutics, Inc. (TNGX) by Ecor1 Capital, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | TNGX | 0 | $0 | 2,700,000 | $8,637,863 | 0 | $0 |
Yearly summary of insider trading at Adaptimmune Therapeutics Plc (ADAP) by Ecor1 Capital, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | ADAP | 0 | $0 | 64,052,538 | $6,903,919 | 0 | $0 |
Yearly summary of insider trading at Surface Oncology, Inc. (SURF) by Ecor1 Capital, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | SURF | 0 | $0 | 332,780 | $2,376,714 | 0 | $0 |
Yearly summary of insider trading at Zymeworks Inc. (ZYME) by Ecor1 Capital, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | ZYME | 534,202 | $7,217,236 | 0 | $0 | 0 | $0 |
| 2023 | ZYME | 4,842,600 | $41,482,073 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Corvus Pharmaceuticals, Inc. (CRVS) by Ecor1 Capital, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | CRVS | 0 | $0 | 5,000,000 | $25,059,999 | 0 | $0 |
Yearly summary of insider trading at Iteos Therapeutics, Inc. (ITOS) by Ecor1 Capital, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | ITOS | 4,958,978 | $38,686,391 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Anaptysbio, Inc (ANAB) by Ecor1 Capital, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | ANAB | 273,972 | $9,999,978 | 0 | $0 | 0 | $0 |
| 2021 | ANAB | 3,338,300 | $63,375,164 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Prothena Corp Public Ltd Co (PRTA) by Ecor1 Capital, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | PRTA | 0 | $0 | 6,279,684 | $50,838,781 | 0 | $0 |
| 2022 | PRTA | 1,362,736 | $42,090,898 | 1,062,736 | $30,840,598 | 0 | $0 |
| 2021 | PRTA | 1,607,640 | $33,194,455 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Voyager Therapeutics, Inc. (VYGR) by Ecor1 Capital, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | VYGR | 0 | $0 | 902,400 | $7,142,467 | 0 | $0 |
| 2022 | VYGR | 477,400 | $2,662,149 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Odonate Therapeutics, Inc. (ODT) by Ecor1 Capital, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | ODT | 185,941 | $308,662 | 5,887,610 | $9,504,457 | 0 | $0 |
Insider trading activities at 11 companies by Ecor1 Capital, Llc:
1. Akouos, Inc. (AKUS)
2. Tango Therapeutics, Inc. (TNGX)
3. Adaptimmune Therapeutics Plc (ADAP)
4. Surface Oncology, Inc. (SURF)
5. Zymeworks Inc. (ZYME)
6. Corvus Pharmaceuticals, Inc. (CRVS)
7. Iteos Therapeutics, Inc. (ITOS)
8. Anaptysbio, Inc (ANAB)
9. Prothena Corp Public Ltd Co (PRTA)
10. Voyager Therapeutics, Inc. (VYGR)
11. Odonate Therapeutics, Inc. (ODT)
Table 1. Insider trading of Akouos, Inc. (AKUS) by Ecor1 Capital, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-06-30 | AKUS | Buy | 1,176,000 | 17.00 | 19,992,000 |
Table 2. Insider trading of Tango Therapeutics, Inc. (TNGX) by Ecor1 Capital, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-11-06 | TNGX | Sale | 1,494,558 | 3.28 | 4,896,172 |
| 2024-11-07 | TNGX | Sale | 1,205,442 | 3.10 | 3,741,691 |
Table 3. Insider trading of Adaptimmune Therapeutics Plc (ADAP) by Ecor1 Capital, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-07-28 | ADAP | Sale | 33,931,740 | .11 | 3,834,286 |
| 2025-07-29 | ADAP | Sale | 2,687,460 | .10 | 271,433 |
| 2025-07-30 | ADAP | Sale | 27,433,338 | .10 | 2,798,200 |
Table 4. Insider trading of Surface Oncology, Inc. (SURF) by Ecor1 Capital, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-09-01 | SURF | Sale | 332,780 | 7.14 | 2,376,714 |
Table 5. Insider trading of Zymeworks Inc. (ZYME) by Ecor1 Capital, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-01-16 | ZYME | Buy | 121,681 | 13.88 | 1,689,540 |
| 2025-01-17 | ZYME | Buy | 19,748 | 13.88 | 274,003 |
| 2025-01-15 | ZYME | Buy | 39,029 | 14.01 | 546,679 |
| 2025-01-14 | ZYME | Buy | 54,500 | 13.56 | 739,292 |
| 2025-01-13 | ZYME | Buy | 74,125 | 13.39 | 992,904 |
| 2025-01-08 | ZYME | Buy | 21,021 | 14.07 | 295,828 |
| 2025-01-10 | ZYME | Buy | 204,098 | 13.13 | 2,678,990 |
| 2023-06-16 | ZYME | Buy | 3,350,000 | 8.12 | 27,201,999 |
| 2023-03-28 | ZYME | Buy | 200,000 | 8.00 | 1,600,000 |
| 2023-01-19 | ZYME | Buy | 144,100 | 9.49 | 1,367,653 |
| 2023-01-20 | ZYME | Buy | 163,400 | 9.88 | 1,615,045 |
| 2023-01-13 | ZYME | Buy | 342,100 | 9.81 | 3,354,632 |
| 2023-01-17 | ZYME | Buy | 440,000 | 9.80 | 4,313,760 |
| 2023-01-18 | ZYME | Buy | 203,000 | 9.99 | 2,028,984 |
Table 6. Insider trading of Corvus Pharmaceuticals, Inc. (CRVS) by Ecor1 Capital, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-10-01 | CRVS | Sale | 2,000,000 | 4.96 | 9,928,000 |
| 2021-09-30 | CRVS | Sale | 3,000,000 | 5.04 | 15,131,999 |
Table 7. Insider trading of Iteos Therapeutics, Inc. (ITOS) by Ecor1 Capital, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-05-14 | ITOS | Buy | 1,658,978 | 7.41 | 12,286,391 |
| 2025-05-15 | ITOS | Buy | 3,300,000 | 8.00 | 26,400,000 |
Table 8. Insider trading of Anaptysbio, Inc (ANAB) by Ecor1 Capital, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-08-14 | ANAB | Buy | 273,972 | 36.50 | 9,999,978 |
| 2021-03-08 | ANAB | Buy | 2,777,800 | 18.97 | 52,694,866 |
| 2021-03-09 | ANAB | Buy | 531,000 | 18.70 | 9,928,638 |
| 2021-02-23 | ANAB | Buy | 29,500 | 25.48 | 751,660 |
Table 9. Insider trading of Prothena Corp Public Ltd Co (PRTA) by Ecor1 Capital, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-05-02 | PRTA | Sale | 3,317,938 | 8.36 | 27,744,597 |
| 2025-05-06 | PRTA | Sale | 1,984,053 | 7.64 | 15,164,117 |
| 2025-05-05 | PRTA | Sale | 977,693 | 8.11 | 7,930,067 |
| 2022-05-05 | PRTA | Buy | 1,062,736 | 29.02 | 30,840,598 |
| 2022-05-05 | PRTA | Sale | 1,062,736 | 29.02 | 30,840,598 |
| 2022-01-12 | PRTA | Buy | 300,000 | 37.50 | 11,250,300 |
| 2021-03-24 | PRTA | Buy | 875,000 | 20.75 | 18,156,250 |
| 2021-02-24 | PRTA | Buy | 10,800 | 22.02 | 237,869 |
| 2021-02-23 | PRTA | Buy | 44,400 | 21.05 | 934,531 |
| 2021-02-18 | PRTA | Buy | 44,100 | 3.68 | 162,111 |
| 2021-02-16 | PRTA | Buy | 89,200 | 22.78 | 2,031,976 |
| 2021-02-17 | PRTA | Buy | 198,840 | 23.46 | 4,665,581 |
| 2021-02-12 | PRTA | Buy | 345,300 | 20.29 | 7,006,137 |
Table 10. Insider trading of Voyager Therapeutics, Inc. (VYGR) by Ecor1 Capital, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-01-11 | VYGR | Sale | 110,000 | 8.50 | 934,670 |
| 2023-01-09 | VYGR | Sale | 456,000 | 7.67 | 3,498,432 |
| 2023-01-10 | VYGR | Sale | 336,400 | 8.05 | 2,709,365 |
| 2022-06-21 | VYGR | Buy | 101,400 | 5.28 | 535,493 |
| 2022-06-23 | VYGR | Buy | 376,000 | 5.66 | 2,126,656 |
Table 11. Insider trading of Odonate Therapeutics, Inc. (ODT) by Ecor1 Capital, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-12-01 | ODT | Buy | 185,941 | 1.66 | 308,662 |
| 2021-12-09 | ODT | Sale | 156,669 | 1.82 | 284,980 |
| 2021-12-10 | ODT | Sale | 5,545,000 | 1.61 | 8,910,815 |
| 2021-12-01 | ODT | Sale | 185,941 | 1.66 | 308,662 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Ecor1 Capital, Llc
(Officer of Adaptimmune Therapeutics Plc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.